Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 13(1): 21675, 2023 12 07.
Artigo em Inglês | MEDLINE | ID: mdl-38065990

RESUMO

In the last decade, clinical studies have investigated the clinical relevance of circulating cell-free-DNA (ccfDNA) as a diagnostic and prognosis tool in various diseases including cancers. However, limited knowledge on ccfDNA biology restrains its full development in the clinical practice. To improve our understanding, we evaluated the impact of the circadian rhythm on ccfDNA release in healthy subjects over a 24-h period. 10 healthy female subjects underwent blood sampling at 8am and 20 healthy male subjects underwent serial blood sampling (8:00 AM, 9:00 AM, 12:00 PM, 4:00 PM, 8:00 PM, 12:00 AM, 4 AM (+ 1 Day) and 8 AM (+ 1 Day)). We performed digital droplet-based PCR (ddPCR) assays to target 2 DNA fragments (69 & 243 bp) located in the KRAS gene to determine the ccfDNA concentration and fragmentation profile. As control, half of the samples were re-analyzed by capillary miniaturized electrophoresis (BIAbooster system). Overall, we did not detect any influence of the circadian rhythm on ccfDNA release. Instead, we observed a decrease in the ccfDNA concentration after meal ingestion, suggesting either a post-prandial effect or a technical detection bias due to a higher plasma load in lipids and triglycerides. We also noticed a potential effect of gender, weight and creatinine levels on ccfDNA concentration.


Assuntos
Ácidos Nucleicos Livres , Humanos , Masculino , Feminino , Voluntários Saudáveis , Prognóstico , Reação em Cadeia da Polimerase , DNA , Ritmo Circadiano
2.
Front Oncol ; 11: 639675, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34094923

RESUMO

Background: Cellular-cell free-DNA (ccfDNA) is being explored as a diagnostic and prognostic tool for various diseases including cancer. Beyond the evaluation of the ccfDNA mutational status, its fragmentation has been investigated as a potential cancer biomarker in several studies. However, probably due to a lack of standardized procedures dedicated to preanalytical and analytical processing of plasma samples, contradictory results have been published. Methods: ddPCR assays allowing the detection of KRAS wild-type and mutated sequences (KRAS p.G12V, pG12D, and pG13D) were designed to target different fragments sizes. Once validated on fragmented and non-fragmented DNA extracted from cancer cell lines, these assays were used to investigate the influence of the extraction methods on the non-mutated and mutated ccfDNA integrity reflected by the DNA integrity index (DII). The DII was then analyzed in two prospective cohorts of metastatic colorectal cancer patients (RASANC study n = 34; PLACOL study n = 12) and healthy subjects (n = 49). Results and Discussion: Our results demonstrate that ccfDNA is highly fragmented in mCRC patients compared with healthy individuals. These results strongly suggest that the characterization of ccfDNA integrity hold great promise toward the development of a universal biomarker for the follow-up of mCRC patients. Furthermore, they support the importance of standardization of sample handling and processing in such analysis.

3.
Pediatr Nephrol ; 20(4): 465-9, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15682315

RESUMO

Nephrotic syndrome (NS) in infancy includes NS of Finnish type (mutation of the nephrin gene), diffuse mesangial sclerosis (idiopathic or linked to WT1 mutation), idiopathic NS, most often steroid resistant, and NS related to infections during pregnancy (virus, syphilis, toxoplasmosis). Later in life, NS has a large variety of etiologies. It has been described in association with neuromuscular symptoms, deafness, and diabetes in a few children and adults with respiratory chain (RC) disorders. To date, however, NS has never been observed in neonates with RC disorders. Here, we report RC deficiency in one infant with certain congenital NS and two siblings with acute neonatal cardiac and renal disease with probable NS. Although clinical and histopathological presentations were initially close to congenital NS of Finnish type, clinical outcome was atypical and nephrin mutation was excluded. Mitochondrial RC complex II+V deficiency was identified in the three patients. Based on these observations, we suggest that RC disorders should be considered in patients with congenital NS.


Assuntos
Doenças Mitocondriais/diagnóstico , Síndrome Nefrótica/congênito , Síndrome Nefrótica/diagnóstico , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Recém-Nascido , Rim/patologia , Masculino , Proteínas de Membrana , Doenças Mitocondriais/metabolismo , Síndrome Nefrótica/genética , Síndrome Nefrótica/patologia , Proteínas/genética
4.
J Med Chem ; 46(24): 5230-7, 2003 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-14613325

RESUMO

In this study we report the synthesis of a series of new amphiphilic compounds derived from alpha-phenyl-N-tert-butylnitrone (PBN). The nitrone function was fitted into the core of the molecule between its polar and apolar groups. The polar head consisted of a lactobionamide, an ammonium, or a carboxylate group. The hydrophobic part consisted of a hydro- or a perfluorocarbon chain. The hydrophobic chain was linked to the tert-butyl group of the PBN derivatives using an urethane, a thioether, or an amide bond. The impact of these different parameters on the hydrophilic lipophilic balance of these compounds and their spin trap activity were studied. The various ESR measurements indicated that the aromatic and tert-butyl functional groups of PBN did not affect its spin trap properties. Moreover, these compounds were found to increase the viability of cultured human skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa mutation and presenting a severe ATPase deficiency.


Assuntos
Sequestradores de Radicais Livres/síntese química , Óxidos de Nitrogênio/síntese química , Adenosina Trifosfatases/deficiência , Ataxia/genética , Permeabilidade da Membrana Celular , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Óxidos N-Cíclicos , Espectroscopia de Ressonância de Spin Eletrônica , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Sequestradores de Radicais Livres/química , Sequestradores de Radicais Livres/farmacologia , Humanos , Interações Hidrofóbicas e Hidrofílicas , Miopatias Mitocondriais/genética , Mutação , Óxidos de Nitrogênio/química , Óxidos de Nitrogênio/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Retinose Pigmentar/genética , Relação Estrutura-Atividade , Síndrome
5.
Free Radic Res ; 36(4): 375-9, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12069100

RESUMO

The oxidative stress possibly resulting from an inherited respiratory chain (RC) deficiency was investigated in a series of human cultured skin fibroblasts presenting either ubiquinone depletion or isolated defect of the various RC complexes. Taken as an index for superoxide overproduction, a significant induction of superoxide dismutase activity was observed in complex V-deficient fibroblasts harboring the NARP-mutation in the ATPase 6 gene. Superoxide dismutase induction was also noticed, albeit to a lesser extent, in complex II-deficient fibroblasts with a mutation in the nuclear gene encoding the flavoprotein subunit of the succinate dehydrogenase. No sign of oxidative stress could be found in ubiquinone-depleted fibroblasts. In all cases but complex IV-defect, increased oxidative stress was associated with increased cell death. In glucose-rich medium, apoptosis appeared as the main cell death process associated with all types of RC defect. However, similar to the great variations in oxidative stress associated with the various types of RC defect, we found that apoptotic features differed noticeably between defects. No indication of increased cell death was found in ubiquinone-depleted fibroblasts.


Assuntos
Antioxidantes/metabolismo , Apoptose/efeitos dos fármacos , Doenças Mitocondriais/metabolismo , Pele/efeitos dos fármacos , Ubiquinona/análogos & derivados , Ubiquinona/deficiência , Aconitato Hidratase/metabolismo , Anexina A5/metabolismo , Biópsia , Caspase 3 , Caspases/metabolismo , Células Cultivadas , Coenzimas , Citoproteção , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Humanos , Marcação In Situ das Extremidades Cortadas , Isocitrato Desidrogenase/metabolismo , Estresse Oxidativo , Pele/metabolismo , Superóxido Dismutase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA